DMAC Earnings

Quarterly EPS
$-0.15
Q3 2024
$-0.18
Q4 2024
$-0.18
Q1 2025
$-0.18
Q2 2025
$-0.17
Q3 2025
$-0.17
Q4 2025
$-0.19
Q1 2026
$-0.19
Q2 2026
Latest RevenueN/A
Latest Net Income-10139000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.190-10139000—-5.6%
Q1 2026-$0.190-10042000—-5.6%
Q4 2025-$0.170-8740000—+5.6%
Q3 2025-$0.170-8620000—-13.3%
Q2 2025-$0.180-7699000—-38.5%
Q1 2025-$0.180-7707000—-28.6%
Q4 2024-$0.180-7900000—-38.5%
Q3 2024-$0.150-6274000—-25.0%
Q2 2024-$0.130-5119000——
Q1 2024-$0.140-5151000——
Q4 2023-$0.130-5161000——
Q3 2023-$0.120-4471000——
DiaMedica Therapeutics (DMAC) — Earnings